Alternative splicing modulates cancer aggressiveness: role in EMT/metastasis and chemoresistance
出版年份 2021 全文链接
标题
Alternative splicing modulates cancer aggressiveness: role in EMT/metastasis and chemoresistance
作者
关键词
-
出版物
MOLECULAR BIOLOGY REPORTS
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2021-01-05
DOI
10.1007/s11033-020-06094-y
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Oncogenic functions of the EMT-related transcription factor ZEB1 in breast cancer
- (2020) Hua-Tao Wu et al. Journal of Translational Medicine
- TGF-β1 promotes epithelial-to-mesenchymal transition and stemness of prostate cancer cells by inducing PCBP1 degradation and alternative splicing of CD44
- (2020) Qi Chen et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Phytochemicals modulate cancer aggressiveness: A review depicting the anticancer efficacy of dietary polyphenols and their combinations
- (2020) Tulika Mitra et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Role of Wnt/β-Catenin Signaling in the Chemoresistance Modulation of Colorectal Cancer
- (2020) Shengli Yuan et al. Biomed Research International
- Correlation of PKM2 and CD44 Protein Expression with Poor Prognosis in Platinum-Treated Epithelial Ovarian Cancer: A Retrospective Study
- (2020) Chara Papadaki et al. Cancers
- MYCT1 inhibits the EMT and migration of laryngeal cancer cells via the SP1/miR-629-3p/ESRP2 pathway
- (2020) Peng-Jie Yue et al. CELLULAR SIGNALLING
- The role of CD44 in pathological angiogenesis
- (2020) Li Chen et al. FASEB JOURNAL
- Splicing factor ESRP1 controls ER‐positive breast cancer by altering metabolic pathways
- (2019) Yesim Gökmen‐Polar et al. EMBO REPORTS
- CD44 splice isoform switching determines breast cancer stem cell state
- (2019) Honghong Zhang et al. GENES & DEVELOPMENT
- The Prognostic and Clinical Value of CD44 in Colorectal Cancer: A Meta-Analysis
- (2019) Zhenpeng Wang et al. Frontiers in Oncology
- Afatinib and Temozolomide combination inhibits tumorigenesis by targeting EGFRvIII-cMet signaling in glioblastoma cells
- (2019) Raghupathy Vengoji et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Matrix Hyaluronan-CD44 Interaction Activates MicroRNA and LncRNA Signaling Associated With Chemoresistance, Invasion, and Tumor Progression
- (2019) Lilly Y. W. Bourguignon Frontiers in Oncology
- Dietary-phytochemical mediated reversion of cancer-specific splicing inhibits Warburg effect in head and neck cancer
- (2019) Sandhya Yadav et al. BMC CANCER
- Hyaluronan-CD44 axis orchestrates cancer stem cell functions
- (2019) Spyros S. Skandalis et al. CELLULAR SIGNALLING
- Addiction of mesenchymal phenotypes on the FGF/FGFR axis in oral squamous cell carcinoma cells
- (2019) Asami Hotta Osada et al. PLoS One
- Integrated Analysis of Structural Variation and RNA Expression of FGFR2 and Its Splicing Modulator ESRP1 Highlight the ESRP1amp-FGFR2norm-FGFR2-IIIchigh Axis in Diffuse Gastric Cancer
- (2019) Sara Pinto Teles et al. Cancers
- Splicing Dysregulation as Oncogenic Driver and Passenger Factor in Brain Tumors
- (2019) Pamela Bielli et al. Cells
- Epithelial Splicing Regulatory Protein 1 Inhibits the Invasion and Metastasis of Lung Adenocarcinoma
- (2018) Lingmei Li et al. AMERICAN JOURNAL OF PATHOLOGY
- Aberrant FGFR tyrosine kinase signaling enhances the Warburg effect by reprogramming LDH isoform expression and activity in prostate cancer
- (2018) Junchen Liu et al. CANCER RESEARCH
- FGFR4 Links Glucose Metabolism and Chemotherapy Resistance in Breast Cancer
- (2018) Min Xu et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- The role of alternative splicing in cancer drug resistance
- (2018) Zahava Siegfried et al. CURRENT OPINION IN GENETICS & DEVELOPMENT
- Role of fibroblast growth factor receptor-2 splicing in normal and cancer cells
- (2018) Toshiyuki Ishiwata Frontiers in Bioscience-Landmark
- Stemness and chemoresistance are imparted to the OC cells through TGFβ1 driven EMT
- (2018) Tulika Mitra et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Mesenchymal splice isoform of CD44 (CD44s) promotes EMT/invasion and imparts stem-like properties to ovarian cancer cells
- (2018) Rahul Bhattacharya et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- FGF9-induced ovarian cancer cell invasion involves VEGF-A/VEGFR2 augmentation by virtue of ETS1 upregulation and metabolic reprogramming
- (2018) Rahul Bhattacharya et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- The biology and role of CD44 in cancer progression: therapeutic implications
- (2018) Chen Chen et al. Journal of Hematology & Oncology
- CD44 exerts a functional role during EMT induction in cisplatin-resistant head and neck cancer cells
- (2018) Hiroaki Miyazaki et al. Oncotarget
- Alternative-splicing defects in cancer: Splicing regulators and their downstream targets, guiding the way to novel cancer therapeutics
- (2018) Laura M. Urbanski et al. Wiley Interdisciplinary Reviews-RNA
- Cancer-associated MORC2 mutant M276I regulates an hnRNPM-mediated CD44 splicing switch to promote invasion and metastasis in triple-negative breast cancer
- (2018) Fang-Lin Zhang et al. CANCER RESEARCH
- Coregulation of alternative splicing by hnRNPM and ESRP1 during EMT
- (2018) Samuel E. Harvey et al. RNA
- Overexpression of CD44 Variant 9: A Novel Cancer Stem Cell Marker in Human Cholangiocarcinoma in Relation to Inflammation
- (2018) Nattawan Suwannakul et al. MEDIATORS OF INFLAMMATION
- The long non-coding RNA MALAT1 promotes ovarian cancer progression by regulating RBFOX2-mediated alternative splicing
- (2018) Michael A. Gordon et al. MOLECULAR CARCINOGENESIS
- Aberrant RNA Splicing in Cancer and Drug Resistance
- (2018) Bi-Dar Wang et al. Cancers
- HnRNPM and CD44s expression affects tumor aggressiveness and predicts poor prognosis in breast cancer with axillary lymph node metastases
- (2017) Huizhi Sun et al. GENES CHROMOSOMES & CANCER
- Therapeutic Applications of Targeted Alternative Splicing to Cancer Treatment
- (2017) Jung-Chun Lin INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- ABC Transporters in Cancer Stem Cells: Beyond Chemoresistance
- (2017) Romana-Rea Begicevic et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Isoform switch of CD44 induces different chemotactic and tumorigenic ability in gallbladder cancer
- (2017) Takeshi Miwa et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- The CD44 standard isoform contributes to radioresistance of pancreatic cancer cells
- (2017) Kento Tsubouchi et al. JOURNAL OF RADIATION RESEARCH
- EMT and stemness: flexible processes tuned by alternative splicing in development and cancer progression
- (2017) Davide Pradella et al. Molecular Cancer
- The epithelial to mesenchymal transition (EMT) and cancer stem cells: implication for treatment resistance in pancreatic cancer
- (2017) Pingting Zhou et al. Molecular Cancer
- FOXC1 Regulates FGFR1 Isoform Switching to Promote Invasion Following TGFβ-Induced EMT
- (2017) Alex Hopkins et al. MOLECULAR CANCER RESEARCH
- Stemness in Cancer: Stem Cells, Cancer Stem Cells, and Their Microenvironment
- (2017) Pedro M. Aponte et al. Stem Cells International
- Human cancer cells with stem cell-like phenotype exhibit enhanced sensitivity to the cytotoxicity of IL-2 and IL-15 activated natural killer cells
- (2016) Tao Yin et al. CELLULAR IMMUNOLOGY
- CD44 Expression Level and Isoform Contributes to Pancreatic Cancer Cell Plasticity, Invasiveness, and Response to Therapy
- (2016) Shujie Zhao et al. CLINICAL CANCER RESEARCH
- CD44 correlates with clinicopathological characteristics and is upregulated by EGFR in breast cancer
- (2016) Hanxiao Xu et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- ZEB1 drives epithelial-to-mesenchymal transition in lung cancer
- (2016) Jill E. Larsen et al. JOURNAL OF CLINICAL INVESTIGATION
- Splicing factor ratio as an index of epithelial-mesenchymal transition and tumor aggressiveness in breast cancer
- (2016) Pietro Fici et al. Oncotarget
- Role of EMT in Metastasis and Therapy Resistance
- (2016) Bethany Smith et al. Journal of Clinical Medicine
- The role of HGF/MET and FGF/FGFR in fibroblast-derived growth stimulation and lapatinib-resistance of esophageal squamous cell carcinoma
- (2015) Shin Saito et al. BMC CANCER
- Genome-wide analysis of alternative transcripts in human breast cancer
- (2015) Ji Wen et al. BREAST CANCER RESEARCH AND TREATMENT
- CD44 variant 6 is correlated with peritoneal dissemination and poor prognosis in patients with advanced epithelial ovarian cancer
- (2015) Francisca Tjhay et al. CANCER SCIENCE
- Pancreatic cancer cells express CD44 variant 9 and multidrug resistance protein 1 during mitosis
- (2015) Shizuka Kiuchi et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- A self-enforcing CD44s/ZEB1 feedback loop maintains EMT and stemness properties in cancer cells
- (2015) Bogdan-Tiberius Preca et al. INTERNATIONAL JOURNAL OF CANCER
- The Arkadia-ESRP2 axis suppresses tumor progression: analyses in clear-cell renal cell carcinoma
- (2015) A Mizutani et al. ONCOGENE
- Aberrant RNA splicing in cancer; expression changes and driver mutations of splicing factor genes
- (2015) A Sveen et al. ONCOGENE
- The p53 Isoform Δ133p53β Promotes Cancer Stem Cell Potential
- (2015) Nikola Arsic et al. Stem Cell Reports
- Perspectives of CD44 targeting therapies
- (2014) V. Orian-Rousseau et al. ARCHIVES OF TOXICOLOGY
- Antibody Against CD44s Inhibits Pancreatic Tumor Initiation and Postradiation Recurrence in Mice
- (2014) Ling Li et al. GASTROENTEROLOGY
- Cell type-restricted activity of hnRNPM promotes breast cancer metastasis via regulating alternative splicing
- (2014) Y. Xu et al. GENES & DEVELOPMENT
- HPV16 E5 expression induces switching from FGFR2b to FGFR2c and epithelial-mesenchymal transition
- (2014) Danilo Ranieri et al. INTERNATIONAL JOURNAL OF CANCER
- Epithelial Splicing Regulatory Proteins 1 (ESRP1) and 2 (ESRP2) Suppress Cancer Cell Motility via Different Mechanisms
- (2014) Hiroki Ishii et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Expression levels of SF3B3 correlate with prognosis and endocrine resistance in estrogen receptor-positive breast cancer
- (2014) Yesim Gökmen-Polar et al. MODERN PATHOLOGY
- Transcriptome-wide Landscape of Pre-mRNA Alternative Splicing Associated with Metastatic Colonization
- (2014) Zhi-xiang Lu et al. MOLECULAR CANCER RESEARCH
- Tumor-Specific Isoform Switch of the Fibroblast Growth Factor Receptor 2 Underlies the Mesenchymal and Malignant Phenotypes of Clear Cell Renal Cell Carcinomas
- (2013) Q. Zhao et al. CLINICAL CANCER RESEARCH
- The RNA-binding protein Rbfox2: an essential regulator of EMT-driven alternative splicing and a mediator of cellular invasion
- (2013) C Braeutigam et al. ONCOGENE
- Epithelial splicing regulatory protein 1 is a favorable prognostic factor in pancreatic cancer that attenuates pancreatic metastases
- (2013) J Ueda et al. ONCOGENE
- N-cadherin/FGFR promotes metastasis through epithelial-to-mesenchymal transition and stem/progenitor cell-like properties
- (2013) X Qian et al. ONCOGENE
- Hallmarks of alternative splicing in cancer
- (2013) S Oltean et al. ONCOGENE
- Expression of TP53 Isoforms p53β or p53γ Enhances Chemosensitivity in TP53null Cell Lines
- (2013) Elisabeth Silden et al. PLoS One
- CD44 Staining of Cancer Stem-Like Cells Is Influenced by Down-Regulation of CD44 Variant Isoforms and Up-Regulation of the Standard CD44 Isoform in the Population of Cells That Have Undergone Epithelial-to-Mesenchymal Transition
- (2013) Adrian Biddle et al. PLoS One
- The RNA Binding Protein ESRP1 Fine-Tunes the Expression of Pluripotency-Related Factors in Mouse Embryonic Stem Cells
- (2013) Sharmila Fagoonee et al. PLoS One
- Uncovering the role of p53 splice variants in human malignancy: a clinical perspective
- (2013) Jean-Christophe Bourdon et al. OncoTargets and Therapy
- MBNL1 and RBFOX2 cooperate to establish a splicing programme involved in pluripotent stem cell differentiation
- (2013) Julian P. Venables et al. Nature Communications
- Role of splice variants in the metastatic progression of prostate cancer: Figure 1
- (2012) Rachel M. Hagen et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Modulation of Glucose Metabolism by CD44 Contributes to Antioxidant Status and Drug Resistance in Cancer Cells
- (2012) M. Tamada et al. CANCER RESEARCH
- Targeting the EGFR signaling pathway in cancer therapy
- (2012) Parthasarathy Seshacharyulu et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Snail Represses the Splicing Regulator Epithelial Splicing Regulatory Protein 1 to Promote Epithelial-Mesenchymal Transition
- (2012) Lauren M. Reinke et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- RBFOX2 Is an Important Regulator of Mesenchymal Tissue-Specific Splicing in both Normal and Cancer Tissues
- (2012) J. P. Venables et al. MOLECULAR AND CELLULAR BIOLOGY
- CD44s and CD44v6 in Diagnosis and Prognosis of Human Bladder Cancer
- (2012) Ola M. Omran et al. ULTRASTRUCTURAL PATHOLOGY
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- CD44 splice isoform switching in human and mouse epithelium is essential for epithelial-mesenchymal transition and breast cancer progression
- (2011) Rhonda L. Brown et al. JOURNAL OF CLINICAL INVESTIGATION
- An EMT–Driven Alternative Splicing Program Occurs in Human Breast Cancer and Modulates Cellular Phenotype
- (2011) Irina M. Shapiro et al. PLoS Genetics
- Reduced Expression of Fibroblast Growth Factor Receptor 2IIIb in Hepatocellular Carcinoma Induces a More Aggressive Growth
- (2010) Thomas Amann et al. AMERICAN JOURNAL OF PATHOLOGY
- Fibroblast growth factor receptor 3-IIIc mediates colorectal cancer growth and migration
- (2010) G Sonvilla et al. BRITISH JOURNAL OF CANCER
- Paths of FGFR-driven tumorigenesis
- (2010) Victor D. Acevedo et al. CELL CYCLE
- An ESRP-regulated splicing programme is abrogated during the epithelial–mesenchymal transition
- (2010) Claude C Warzecha et al. EMBO JOURNAL
- ZEB1 in Pancreatic Cancer
- (2010) Ulrich Wellner et al. Cancers
- Metastasis mechanisms
- (2009) Thomas R. Geiger et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Conserved intron positions in FGFR genes reflect the modular structure of FGFR and reveal stepwise addition of domains to an already complex ancestral FGFR
- (2009) Nicole Rebscher et al. DEVELOPMENT GENES AND EVOLUTION
- The basics of epithelial-mesenchymal transition
- (2009) Raghu Kalluri et al. JOURNAL OF CLINICAL INVESTIGATION
- Mechanisms of alternative splicing regulation: insights from molecular and genomics approaches
- (2009) Mo Chen et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Snail and Slug Mediate Radioresistance and Chemoresistance by Antagonizing p53-Mediated Apoptosis and Acquiring a Stem-Like Phenotype in Ovarian Cancer Cells
- (2009) Nawneet K. Kurrey et al. STEM CELLS
- A p120 Catenin Isoform Switch Affects Rho Activity, Induces Tumor Cell Invasion, and Predicts Metastatic Disease
- (2008) Masahiro Yanagisawa et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Alternative isoform regulation in human tissue transcriptomes
- (2008) Eric T. Wang et al. NATURE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started